Okay, I want to keep the spirit of the survey, giving those that participated a voice, but still do the condensed version.

So I thought keep the sections with questions most critical to the share price.



Combo KEEP
BLA submission timeline if FDA requires 700mg?
Anticipation date FDA will give final safety data requirements?
When will the 700mg safety data with the 100 patients be complete?





Mono -- Knowing meeting date will not change sp, TOSS

Update on FDA meeting date? (Anticipated date for meeting?)

TNBC -NP will update tonight on injections, so. I doubt we get any additional information over what he gives TOSS

Recruiting status on the open TNBC site? Patients screened yet?
Any update on your investigation into the TNBC trial delays?
Updates on remaining sites opening? IRB approval for these yet?

Remaining (GvHD, Cancer, NASH, MS ) TOSS

Status updates: GvHD enrollment, NASH study, any of the 8 cancer pre-clinical trials started, Colon Cancer IND, MS plans.


Financing / License Agreement / Partnerships: KEEP

Updates on Prognostic test license? Is this pending 510(k) FDA decision?
Updates on commercialization pharma company agreement related to HIV and GVHD? Or does CYDY expect to commercialize Leronlimab?
Terms discussed in non-binding term sheet that was verbally accepted pending BOD approval from China investment?
Any progression in Samsung capital investment?
Updates on mid-tier pharma partnership?


Other: TOSS